Abstract: This invention relates to a liquid herbicidal composition comprising a non-aqueous solvent system, at least one sulfonylurea herbicide and at least one inorganic salt selected from the metal carbonates and metal phosphates. The invention also relates to the use of an inorganic salt selected from the metal carbonates and metal phosphates to improve chemical stabilisation of a sulfonylurea herbicide in a liquid composition comprising a non-aqueous solvent system.

Abstract: Bioactive priming polypeptides are provided that are useful when applied to plants in agricultural formulations. Methods of using the formulations containing the bioactive priming polypeptides are also provided which are applied exogenously to the surface of a plant or a plant cell membrane or endogenously to the interior of a plant or to a plant cell. The bioactive priming polypeptides when applied to a plant, a plant part, or a plant growth medium or a rhizosphere in an area surrounding the plant or the plant part increase growth, yield, health, longevity, productivity, and/or vigor of a plant or a plant part and/or decrease abiotic stress in the plant or the plant part and/or protect the plant or the plant part from disease, insects and/or nematodes, and/or increase the innate immune response of the plant or the plant part and/or change plant architecture.

Abstract: A platform drug delivery system and a method of improving the delivery of low solubility pharmaceuticals utilizing crystal engineering and Theanine dissolution resulting in enhanced bioactivity, dissolution rate, and solid state stability.

Abstract: The present disclosure relates to methods and devices for controlling arthropods, including insects and arachnids in an environment. The methods generally comprise: generating a near-ideal gas Purified Hydrogen Peroxide Gas (PHPG) that is substantially non-hydrated (e.g., in the form of water in solution or water in solution or water molecules bonded by covalence, van der Waals forces, or London forces) and substantially free of, e.g., ozone, plasma species, and/or organic species; and directing the gas comprising primarily PHPG into the environment such that the PHPG acts to control arachnids in the environment. In certain aspects, the arachnids may be totally or partially killed.

Abstract: The present invention relates to a transdermal therapeutic system for cutaneous administration of fampridine. The system includes an active ingredient-impermeable backing layer, a pressure-sensitive adhesive reservoir layer and optionally a detachable protective layer. The pressure-sensitive adhesive reservoir layer is formed from fampridine and at least one matrix polymer containing no free carboxylic acid and/or carboxylate groups, with the content of fampridine in the matrix polymer being <5% by weight. On account of the low loading and also the lack of carboxylic acid and/or carboxylate groups in the reservoir layer, it is ensured that the systems administer the active ingredient substantially at higher administration rates than is known in the prior art, and compared to known systems a comparable thermodynamic activity of the active ingredient is achieved. The present invention further relates to a process for producing corresponding transdermal therapeutic systems.

Abstract: The present invention relates to compounds of Formula (I) or an agronomically acceptable salt of said compounds wherein Q, R1, R2, n and m are as defined herein. The invention further relates to herbicidal compositions which comprise a compound of Formula (I) and to the use of compounds of Formula (I) for controlling weeds, in particular in crops of useful plants.

Abstract: The present invention relates to sustained release tablet comprising micronized tolcapone, a release retardant and a binder, to said tablet for use in the prevention and/or treatment of a transthyretin-associated amyloidosis, to a method for the prevention and/or treatment of a transthyretin-associated amyloidosis comprising administering to a subject in need thereof an effective amount of said tablet, to pharmaceutical composition in the form of said tablet which is used in the prevention and/or treatment of a transthyretin-associated amyloidosis and to a process for the manufacture of said tablet.

Abstract: Disclosed herein is a herbicide and methods for the control of a grass or a broadleaf weed in a crop. The herbicide comprises an effective amount glufosinate, or a salt thereof, and an effective amount of a metabolic inhibitor.

Abstract: A nano-coated polymeric antimicrobial film including a polymer and a metallic glassy powder coating on the polymer. The polymer includes a polymeric material selected from a virgin linear low-density polyethylene (LLDPE), a plastic solid waste (PSW), and a bio-based plastic. The metallic glassy powder is selected from the group consisting of Cu53.3Zr25.5Nb12.9Ni8.3, CuZn54Zr25Nb14Ni7, Cu48Ti17Ni28Zr5Ag2, and Cu85/SUS316L10/Ag5. The resulting nano-coated polymeric antimicrobial film has anti-microbial protective effects and may be applied to surfaces where anti-microbial activity is desired.

Abstract: Multi-species pest control methods, which contact or subject a target pest to a yeast strain belonging to the species Pichia kluyveri and/or with a lysate, filtrate, isolate or extract thereof. The yeast strain belonging to the species Pichia kluyveri and/or the lysate, filtrate, isolate or extract thereof is incorporated into the body of the agricultural target pest.

Abstract: A detergent-free decellularized ECM preparation method, a detergent-free decellularized ECM in a powder form and in a liquid form, a method of preparation of a primary bioink, the primary bioink, a method of preparation of a vascular bioink, the vascular bioink, a three dimensional structure including the primary bioink and/or the vascular bioink and a method of preparation of the three-dimensional structure.

Abstract: A method for stabilizing a bioactive herbaceous extract in a composition comprising silicon particles, the method comprising bringing the bioactive herbaceous extract into contact with the silicon particles, in the presence of at least one non-reducing disaccharide. Also related compositions and methods.

Abstract: The present invention relates to polymeric particles comprising a biodegradable polymer, and at least one microorganism in a total concentration of at least 108 CFU/g dry weight that is stable for at least 35 weeks at 30° C. and optionally additional carriers and additives as well as to methods for producing polymeric particles and use thereof.

Abstract: The present invention provides a method for controlling the degradation of emamectin and cartap, the method comprising formulating a composition which comprises an amount of water less than 0.5% by weight based on the total weight of the stable composition and at least one pH adjuster for maintaining the pH at 25° C. after dilution in water at less than 5.5. The present invention further provides a stable solid insecticidal composition comprising: (1) an effective amount of emamectin; (2) an effective amount of cartap; and (3) at least one pH adjuster; wherein the composition is substantially free of water and the pH at 25° C. after dilution with water is less than 5.5.

Abstract: In some aspects, the present disclosure pertains to a polymer that comprises a plurality of polymer arms, wherein a first portion of the polymer arms comprise a reactive end group and wherein a second portion of the polymer arms comprise a branched end group that comprise a plurality of covalently attached diagnostic and/or therapeutic groups, which may be, for example, radiocontrast groups or radioactive groups. Other aspects pertain to a system that comprises (a) a first composition comprising such a polymer and (b) a second composition comprising a multifunctional compound that comprises reactive functional groups that are reactive with the reactive end group of the multi-arm polymer. Still other aspects pertain to a crosslinked reaction product of (a) such a polymer and (b) a multifunctional compound that comprises functional groups that are reactive with the reactive end group of the multi-arm polymer.

Abstract: A 2-(benzo[d]oxazol-2-yl)-N?-(isonicotinoyloxy)acetimidamide compound, its synthesis, and its use as an antimicrobial agent.

Abstract: A 2-(benzo[d]oxazol-2-yl)-N?-(isonicotinoyloxy)acetimidamide compound, its synthesis, and its use as an antimicrobial agent.

Abstract: A 2-(benzo[d]oxazol-2-yl)-N?-(isonicotinoyloxy)acetimidamide compound, its synthesis, and its use as an antimicrobial agent.

Abstract: Disclosed are polymers, methods of making polymers, and compositions, focused on cross-linking heterocycles comprising a moiety of Formula I with thiols and thiolates.

Abstract: This document provides methods and materials for treating lung conditions induced by inhalable insulin therapy. For example, compositions including a dried amnion tissue preparation and/or a dried stem cell preparation as well as methods for using such compositions to treat inhalable insulin induced lung conditions are provided.